Rajinder Singh

Rajinder Singh is a Partner at New Enterprise Associates (NEA), one of the world’s leading venture capital firms, where he focuses on identifying, supporting, and scaling transformative companies in the healthcare and life sciences sectors. His responsibilities include sourcing new investment opportunities, conducting rigorous due diligence, and partnering with portfolio company management teams to drive growth and innovation. Singh frequently works with companies developing novel therapeutics, diagnostics, and digital health platforms.

Before joining NEA in 2022, Singh held leadership roles in major pharmaceutical and healthcare companies, including serving as Vice President of Business Development at Johnson & Johnson, where he spearheaded strategic partnerships and M&A initiatives across the healthcare ecosystem. Earlier, he was a Senior Operations Manager at AstraZeneca, managing operational improvements in drug development and portfolio management. These roles provided him with deep industry expertise in biopharma, medical devices, and healthcare technology.

Singh’s educational background includes a degree in Business Administration and Management from Stanford University Graduate School of Business, as well as similar credentials from The University of Manchester. His notable achievements include leading several successful investments and corporate partnerships that have accelerated innovations in precision medicine, biotech, and health IT. Singh is recognized for his cross-sector expertise and his commitment to advancing impactful healthcare solutions.